Finance

Lists
003060:KRX
Aprogen Biologics Inc
1 498,00 KRW
-0,99%
(-15,00) 1D
19 ოქტ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 003060...
Open
1 488 KRW
High
1 519 KRW
Low
1 479 KRW
Mkt. cap
43,39 მლრდ.
Avg. vol.
436,08 ათ.
Volume
78,59 ათ.
52-wk high
9 945 KRW
52-wk low
1 424 KRW
EPS
-5 882 KRW
Shares outstanding
28,97 მლნ.
No. of employees
262
Open
1 488 KRW
High
1 519 KRW
Low
1 479 KRW
Mkt. cap
43,39 მლრდ.
Avg. vol.
436,08 ათ.
Volume
78,59 ათ.
52-wk high
9 945 KRW
52-wk low
1 424 KRW
EPS
-5 882 KRW
Shares outstanding
28,97 მლნ.
No. of employees
262
News stories
From web sources and news partners
About Aprogen Biologics Inc
CEO-
Employees262
Founded1960
Headquarters-
SectorPharmaceutical industry
Websiteen.aprogen-pharm.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
21,12 მლრდ.
20,36 მლრდ.
21,62 მლრდ.
23,08 მლრდ.
Cost of goods sold
23,45 მლრდ.
27,52 მლრდ.
26,38 მლრდ.
32,64 მლრდ.
Cost of revenue
23,45 მლრდ.
27,52 მლრდ.
26,38 მლრდ.
32,64 მლრდ.
Research and development expenses
840,59 მლნ.
903,10 მლნ.
700,20 მლნ.
629,24 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,15 მლრდ.
7,67 მლრდ.
7,88 მლრდ.
7,06 მლრდ.
Operating expense
27,85 მლრდ.
31,11 მლრდ.
11,26 მლრდ.
3,88 მლრდ.
Total operating expenses
51,30 მლრდ.
58,62 მლრდ.
37,65 მლრდ.
36,52 მლრდ.
Operating income
-30,18 მლრდ.
-38,26 მლრდ.
-16,03 მლრდ.
-13,44 მლრდ.
Other non operating income
6,10 მლრდ.
9,91 მლრდ.
13,56 მლრდ.
6,59 მლრდ.
EBT including unusual items
-24,46 მლრდ.
-34,98 მლრდ.
-4,57 მლრდ.
-9,64 მლრდ.
EBT excluding unusual items
-24,01 მლრდ.
48,06 მლრდ.
-3,06 მლრდ.
-15,46 მლრდ.
Income tax expense
65,25 მლნ.
-1,15 მლრდ.
-
25,32 მლნ.
Effective tax rate
-0,27%
3,28%
-
-0,26%
Other operating expenses
261,86 მლნ.
111,24 მლნ.
111,12 მლნ.
115,69 მლნ.
Net income
-24,37 მლრდ.
-36,05 მლრდ.
-3,89 მლრდ.
-13,98 მლრდ.
Net profit margin
-115,42%
-177,02%
-18,00%
-60,58%
Earnings per share
-
-
-
-
Interest and investment income
2,38 მლრდ.
3,97 მლრდ.
3,94 მლრდ.
1,59 მლრდ.
Interest expense
-2,28 მლრდ.
-3,71 მლრდ.
-4,29 მლრდ.
-4,51 მლრდ.
Net interest expenses
101,11 მლნ.
260,31 მლნ.
-342,63 მლნ.
-2,92 მლრდ.
Depreciation and amortization charges
139,95 მლნ.
145,51 მლნ.
113,68 მლნ.
97,62 მლნ.
EBITDA
-25,58 მლრდ.
-33,48 მლრდ.
-11,03 მლრდ.
-8,41 მლრდ.
Gain or loss from assets sale
-46,26 მლნ.
-5,49 მლნ.
190,82 ათ.
34,40 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები